Natrelle® unveils the new “For Every BODY” campaign.

The refreshed look showcases the most diverse portfolio of breast implants for a personalized look

IRVINE, CA., November 8, 2023 /PRNewswire/ — Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, embraces the highly personal choice patients experience when choosing breast surgery. New Natrelle^® the “For Every BODY” campaign, highlights patients and their diverse stories, leveraging new images and visuals that can be seen on www.alookforeverybody.com. The campaign shows how the Natrelle^® Our breast implant portfolio can provide a custom look for every curve, every shape and every BODY.

“Our market research shows how important it is to consumers for breast implant brands to feature a wide range of real, authentic women in their marketing efforts,^1*” he said Carrie Strom, President, Global Allergan Aesthetics and Senior Vice President, AbbVie. “Deciding to have breast surgery is a personal choice, and we’re excited to share our sophisticated visual identity that further celebrates the uniqueness of each woman.”

During market research, consumers who have undergone breast augmentation surgery and those considering breast augmentation also mention the importance of seeing candid images of women engaged in various activities.^1* In addition, consumers said they got to see women with breast implants modeling different looks, helping to show what everyday life with breast implants can look like.^1* This new campaign, once fully launched, will help anyone interested in learning more about breast implants better understand what the real results can be like.

With Natrelle^®patients can get a custom look they love. Natrelle^® is the number one chosen breast implant by plastic surgeons,^2† with a collection of 300 implant options to choose from.³ Natrelle^® offers the most options for smooth breast implants with five profiles from minimum to maximum fullness and three different gels for different levels of softness.^3‡ Gummy describes the consistency of the silicone gel inside Natrelle HOPE^® Breast implants. Each type of implant in Natrelle HOPE^® The collection has a different level of cohesion.^3‡

“Every day in my office, I see a wide range of women who are considering breast surgery for a variety of reasons,” she said. Camille G. Cash, MD, Board Certified Plastic Surgeon. “I’m glad that Natrelle^® she’s taking this first step to show the world how incredible these women are. As their surgeon, I develop a close relationship with them and hope that the Natrelle^® The ‘For Every BODY’ campaign will help more women to better understand the options available to them, making it easier for them to make an informed decision as part of the consultation.”

To learn more and see the rebrand, visit natrelle.com or @Natrelle on YouTube and follow on Instagram @NatrelleBreastAugmentation, @NatrelleBreastReconstruction and #ForEveryBODY.

*Based on March 2023 consumer market research (n=38).

^†Based on July 2023 surgeon data (n=305).

^‡ The significance inside the body has not been established.

Natrelle^® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES

Breast implants are not considered lifetime devices. The longer people have them, the more likely they are to develop complications, some of which will require more surgery.

Breast implants have been associated with the development of a cancer of the immune system called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more often in patients with textured breast implants than with smooth implants, although the rates are not well defined. Some patients have died from BIA-ALCL.

Patients receiving breast implants have reported a variety of systemic symptoms, including joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and more. The risk of individual patients for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.

Who can get breast implants?
Natrelle^® Breast implants are approved for the following:

• Breast enlargement for women at least 22 years old for silicone-filled implants and for women at least 18 years old for saline-filled implants. Breast augmentation includes primary breast augmentation to increase breast size and revision surgery to correct or improve the result of an initial breast augmentation
• Breast reconstruction. This includes primary breast reconstruction to replace breast tissue that has been removed due to cancer or trauma, or that has not developed properly due to a severe breast abnormality. This also includes revision surgery to correct or improve the result of a primary breast reconstruction

Who should NOT get breast implants?
Breast implant surgery should NOT be performed on:

• Women with active infection anywhere on their body
• Women with existing cancer or precancerous breast cancer who have not received adequate treatment for these conditions
• Women who are currently pregnant or breastfeeding

What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:

• Autoimmune diseases (eg lupus and scleroderma)
• A weakened immune system (eg taking medicines to reduce the body’s immune response)
• Scheduled chemotherapy or radiation therapy after breast implant placement
• Conditions or medications that interfere with wound healing and blood clotting
• Decreased blood supply to the breast tissue
• Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders
• Those diagnosed with depression or other mental health disorders should wait for these conditions to resolve or stabilize before undergoing breast implant surgery

What else should I think?

• There is a boxed warning for breast implants. See the text in bold at the beginning
• Many changes to your breasts after implantation are irreversible. If you later choose to have your implants removed and not replaced, you may experience dimples, shrinkage, wrinkling, or other cosmetic changes, which may be permanent
• Breast implants are probably not a one-time surgery. The longer the implants are in place, the greater the potential risk for complications. You will likely need additional surgeries on your breasts due to complications or unacceptable cosmetic results. Therefore, you should also consider the complication rates for later surgery (revision), as you may face these risks in the future
• Cancer treatments and surgeries will affect the outcome and timing of breast reconstruction
• Breast implants can affect your ability to breastfeed, either by reducing or eliminating milk production
• Rupture of a silicone-filled breast implant is most often silent. Even if you have no symptoms, you should have your first ultrasound or MRI at 5 to 6 years after your initial implant surgery and then every 2 to 3 years thereafter, regardless of whether your implants are for augmentation or reconstruction. If you have symptoms or inconclusive ultrasound results for a ruptured breast implant, an MRI is recommended. Additional imaging may be required depending on your medical history and condition. The health consequences of a ruptured silicone gel breast implant have not been fully established
• A routine breast cancer screening mammogram will be more difficult and the implants may break during the procedure. Do a monthly self-exam for cancer screening and ask your surgeon to help you distinguish the implant from your breast tissue. Lumps, persistent pain, swelling, induration, or changes in the shape of the implant should be reported to your surgeon and possibly evaluated with imaging

What are the main complications with breast implants?
Major complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/ripples, nipple complications with implant malposition, hypertrophic scarring, and implant palpability/visibility.

Talk to your doctor about other complications.

For more information, see the patient leaflets at www.allergan.com/products.

To report a problem with Natrelle^® Breast implants, call Allergan^® at 1-800-624-4261.

The sale and distribution of Natrelle^® Breast implants are restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture and market a portfolio of leading brands and aesthetic products. Our aesthetic portfolio includes facial injectables, body contouring, plastic, skin care and more. Our goal is to consistently provide our customers with innovation, education, exceptional service and a commitment to excellence, all with a personal touch. For more information, visit AllerganAesthetics.com.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health problems today and address the medical challenges of tomorrow. We strive to make a remarkable impact on people’s lives in many key therapeutic areas – immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

bibliographical references

1. Allergan. Data in File. Consumer market research. 2023.
2. Surgeon Data Survey. July 2023.
3. Allergan data on file at Natrelle^®. 2023.

SOURCE AbbVie